טוען...
Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence
Patients with type 2 diabetes (T2D) are often overweight/obese and affected by arterial hypertension, dyslipidaemia, and have high serum levels of uric acid. Moreover, T2D patient have a higher risk of developing cardiovascular or renal complications, which are leading causes of morbidity and mortal...
שמור ב:
| הוצא לאור ב: | Diabetes Metab Syndr Obes |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6982447/ https://ncbi.nlm.nih.gov/pubmed/32021362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S233538 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|